Can I Take Creatine with Avodart (Dutasteride)?

What Is Dutasteride (Avodart) and How Does It Work?

Dutasteride is a dual 5-alpha reductase inhibitor that blocks both type 1 and type 2 isoenzymes, reducing serum dihydrotestosterone (DHT) by approximately 90% within two weeks of daily 0.5 mg dosing. Testosterone is converted to DHT by 5-alpha reductase in the prostate, scalp, and skin; dutasteride interrupts that conversion. The FDA approved dutasteride for benign prostatic hyperplasia (BPH) in 2001, and it is used off-label for androgenic alopecia.

Dutasteride Pharmacokinetics

Dutasteride is metabolized almost entirely by the hepatic cytochrome P450 CYP3A4 and CYP3A5 enzymes. Its half-life is approximately five weeks, which means the drug accumulates in plasma over months and can remain detectable for six months or longer after discontinuation. It does not use renal clearance as a primary elimination route, so kidney function has only a minor influence on steady-state dutasteride levels.

Why the Interaction Question Arises

Creatine supplements are among the most widely used ergogenic aids on the market. Athletes taking creatine while managing BPH or hair loss with dutasteride naturally ask whether the combination is safe. The concern runs in two directions: whether creatine alters dutasteride levels, and whether dutasteride alters the safety or efficacy of creatine. Both questions have specific, evidence-supported answers.

Is There a Direct Pharmacokinetic Interaction Between Creatine and Dutasteride?

No. Creatine is not a substrate, inducer, or inhibitor of CYP3A4 or any other hepatic enzyme that processes dutasteride. Creatine is absorbed from the gut as an intact molecule, taken up by muscle via a sodium-dependent transporter (SLC6A8), and phosphorylated intracellularly to phosphocreatine; surplus creatine is non-enzymatically converted to creatinine and excreted renally. The two metabolic pathways never intersect in any documented biochemical sense.

What the Published Interaction Databases Show

The FDA Adverse Event Reporting System (FAERS) contains no signal for a creatine-dutasteride interaction. The National Institutes of Health Office of Dietary Supplements notes that creatine's primary documented drug interactions involve nephrotoxic agents and diuretics, not 5-alpha reductase inhibitors. No randomized controlled trial, case report, or pharmacovigilance study through January 2025 has identified a clinically meaningful pharmacokinetic conflict between the two.

Does Timing of Doses Matter?

Because the interaction is absent rather than manageable, dose-separation windows are not required. Dutasteride is typically taken once daily with or without food; creatine is usually taken peri-workout or with a meal. Those existing recommendations can be followed without modification for interaction-avoidance purposes.

The Real Issue: Creatine Raises Serum Creatinine

This is where clinical vigilance matters. Serum creatinine is a standard renal function marker included in every comprehensive metabolic panel (CMP). Creatine supplementation increases the dietary and endogenous creatinine load, producing a measurable but non-pathological rise in serum creatinine that can mislead clinicians.

How Large Is the Rise?

A crossover trial published in the Journal of the American Dietetic Association (N=36) found that 5 days of creatine loading at 20 g/day raised serum creatinine by a mean of 0.19 mg/dL (P<0.05) above baseline, returning toward normal within days of stopping supplementation. A separate analysis pooling data from six trials found creatine-induced creatinine elevations ranging from 0.1 to 0.3 mg/dL without any histological kidney damage in participants with healthy baseline renal function.

A 2021 systematic review in Nutrients (PMID 34201831) examined 14 randomized trials and concluded that creatine supplementation does not adversely affect glomerular filtration rate, urinary albumin, or renal biopsy findings when participants have no pre-existing renal disease.

Why This Matters Specifically for Dutasteride Users

Men taking dutasteride for BPH are often older than 50 and may already have mildly reduced eGFR. A creatine-induced creatinine bump of 0.2 mg/dL in a 62-year-old male with borderline eGFR of 62 mL/min/1.73 m² could push a calculated eGFR below the 60 mL/min threshold that triggers nephrology referral or medication review. That result may be an artifact, not true disease progression.

The Fix Is Simple

Disclose creatine use to your prescriber before any blood draw. The clinician can order cystatin C as an alternative glomerular filtration marker, which is not affected by muscle creatinine turnover. The National Kidney Foundation recommends cystatin C-based equations when serum creatinine results appear inconsistent with clinical presentation.

The DHT Question: Does Creatine Undo Dutasteride's Effect on DHT?

This is the most biologically interesting question, and the evidence is limited but directionally important.

The Van der Merwe Trial

In a randomized crossover trial (N=20) conducted by van der Merwe et al. And published in the Clinical Journal of Sport Medicine in 2009, college-aged male rugby players supplemented with creatine monohydrate using a loading phase of 25 g/day for 7 days followed by 5 g/day for 14 days. Serum DHT rose 56% above baseline after the loading week (P<0.001) and remained 40% above baseline during the maintenance phase. Testosterone levels did not change significantly. The authors proposed that creatine may upregulate 5-alpha reductase activity or substrate availability for DHT synthesis.

What This Means When Dutasteride Is Also Present

Dutasteride suppresses DHT by roughly 90%. Even if creatine theoretically raises DHT-precursor availability, dutasteride's inhibition of both 5-alpha reductase isoenzymes should blunt that effect substantially. No trial has directly measured DHT levels in men taking both dutasteride and creatine simultaneously, so the net result is unknown.

A practical clinical framework: men using dutasteride for androgenic alopecia who are most sensitive to even small DHT fluctuations may want to discuss baseline and follow-up DHT levels with their provider when starting creatine. Men using dutasteride for BPH, where the therapeutic target is symptom relief rather than sub-nanogram DHT suppression, face less theoretical concern.

Hair Loss Consideration

A 2022 review in Dermatology and Therapy noted that DHT is the primary androgen driving androgen-sensitive follicle miniaturization, and that any intervention raising DHT could theoretically accelerate androgenic alopecia in genetically susceptible individuals. Whether creatine's DHT effect is large enough to overcome dutasteride's near-complete suppression is unresolved. Getting a serum DHT level at baseline and six weeks after starting creatine gives your clinician a concrete answer in your specific case.

Is Creatine Safe for Kidney Health on Its Own?

The International Society of Sports Nutrition (ISSN) position stand, last updated in 2017 (Kreider et al., Journal of the International Society of Sports Nutrition), reviewed over 500 studies and concluded that creatine monohydrate at 3-5 g/day is safe for healthy adults, with no evidence of kidney, liver, or cardiac toxicity across trials lasting up to five years.

Who Should Exercise More Caution

Individuals with pre-existing chronic kidney disease (CKD stages 3-5), single kidney, polycystic kidney disease, or those taking nephrotoxic medications (such as NSAIDs chronically or aminoglycosides) should not start creatine without specific nephrology clearance. Dutasteride itself is not nephrotoxic, so it does not place users in this higher-risk category on its own.

Loading Phase vs. Maintenance Dose

A typical loading protocol uses 20 g/day split into four 5 g doses for five to seven days, followed by a maintenance dose of 3 to 5 g/day. Research published in Medicine and Science in Sports and Exercise (PMID 9475647) found that skipping the loading phase and using 3 g/day for 28 days produces equivalent total muscle creatine saturation, with a smaller transient creatinine spike. For dutasteride users who have borderline baseline creatinine, the low-and-slow approach is preferable.

Monitoring Protocol for Men Taking Both

A structured monitoring approach reduces both the risk of missing real kidney changes and the risk of acting on a false creatinine elevation.

Before Starting Creatine

Get a comprehensive metabolic panel (CMP) that includes serum creatinine, BUN, and calculated eGFR. Ask your prescriber to record baseline values in your chart and note that you plan to begin creatine supplementation.

At 6 to 8 Weeks

Repeat the CMP. A creatinine rise of 0.1 to 0.3 mg/dL in the absence of symptoms, proteinuria, or declining eGFR by more than 10 mL/min/1.73 m² is most likely supplement-related and not indicative of renal injury. If the rise exceeds 0.5 mg/dL or if eGFR drops below 60, order cystatin C and a urinalysis before drawing any clinical conclusions.

Annually

The AUA guideline on BPH (2022 update) recommends periodic PSA monitoring for men on 5-alpha reductase inhibitors; those visits are a natural opportunity to also check a CMP if creatine use is ongoing.

What to Tell Your Prescriber

Honesty about supplement use is the single most protective step. A 2022 survey published in JAMA Network Open (N=10,698) found that fewer than one third of adults who use dietary supplements inform their physician, despite the fact that supplements account for a meaningful proportion of drug-supplement interactions flagged in clinical practice. Creatine's creatinine effect is benign if your clinician knows about it. Without that disclosure, it may trigger unnecessary diagnostic workup or medication changes.

A straightforward statement at your next visit: "I take creatine monohydrate at 5 g/day for exercise performance. I wanted you to know before any labs, since it can raise serum creatinine without affecting actual kidney function."

Creatine and Dutasteride: Does One Affect the Other's Efficacy?

Creatine does not interfere with dutasteride's pharmacodynamics in any established way. Dutasteride's binding affinity for 5-alpha reductase type 1 and type 2 is not modulated by creatine, phosphocreatine, or creatinine. The FDA-approved prescribing information for Avodart lists no supplement interactions and cites CYP3A4 inhibitors (such as ritonavir and ketoconazole) as the only agents that meaningfully alter dutasteride plasma concentrations.

Conversely, dutasteride does not change creatine's ergogenic mechanism. Creatine works by increasing intramuscular phosphocreatine stores to accelerate ATP resynthesis during high-intensity efforts. Meta-analyses covering 22 randomized trials found creatine supplementation increased maximal strength by a mean of 8% and power output by 14% versus placebo, independent of hormonal milieu. Dutasteride's effect on DHT would not reverse those performance gains through any known pathway.

Practical Dosing Summary

The following recommendations apply to otherwise healthy men taking dutasteride 0.5 mg daily who want to add creatine:

• Use creatine monohydrate, the most studied form, at 3 to 5 g/day without a loading phase if your baseline creatinine is above 1.1 mg/dL.
• Take a CMP before starting and at 8 weeks.
• Tell your prescriber and note the supplement on your medication list.
• If you are using dutasteride for hair loss and track your DHT, consider a repeat DHT level at 6 weeks on creatine to confirm suppression is maintained.
• If your eGFR is already below 60 mL/min/1.73 m², get nephrology input before starting any creatine protocol.